GE HealthCare

GE HealthCare Technologies Inc. is a standalone healthcare-technology company that provides medical technology, pharmaceutical diagnostics, and AI, cloud, and software solutions. Its investor materials describe a business serving patients and providers for 130 years, with approximately 54,000 colleagues, customers in more than 160 countries, 2025 revenue of $20.6 billion, and an installed base of about five million units. [1] GE HealthCare completed its separation from General Electric effective January 3, 2023 and began trading independently on Nasdaq under the ticker GEHC on January 4. [2]

The company organizes its current offering across Advanced Imaging Solutions, Pharmaceutical Diagnostics, and Patient Care Solutions. [1] Its imaging activities include molecular imaging, computed tomography, magnetic resonance, women’s health, and X-ray, while its advanced-visualization activities include specialized ultrasound and procedural guidance. [3] Patient Care Solutions includes monitoring and life-support solutions, and Pharmaceutical Diagnostics supplies imaging agents used in diagnostic procedures. [1] [3] GE HealthCare’s precision-care strategy combines imaging, clinical data connectivity, and artificial intelligence to support diagnosis and treatment decisions. [2]

GE HealthCare traces its technical heritage to early medical-imaging work and describes a 125-year innovation legacy that began with some of the earliest X-ray breakthroughs and now extends to AI-enabled devices and connected care. [4] The company’s historical account presents the evolution as a progression from X-ray equipment toward systems that combine images with information about physiology, molecular activity, and treatment response. [4] The 2023 transaction made healthcare a separately governed public company alongside GE’s aviation and energy successors, so GE HealthCare should be treated as its own corporate entity in this database. [2]